Haloperidol Tablet
Product Images NDC 0904-6733
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 0904-6733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 01
This is a description of a medication for HALOPERIDOL in tablet form. The medication is sold in a unit-dose package with 100 tablets. It is meant to treat symptoms such as agitation, anxiety and confusion. There is some indication that the medication should be refrigerated to maintain potency. The text indicates a dosage regimen, but it is unclear whether this is for this specific medication.*
Image 02
This is a description of a Haloperidol tablet, USP, which comes in a unit dose of 100 tablets. It is intended for prescription-only use and the usual dosage can be found on the product insert or prescribing information, both of which can be found at www.majorpharmaceuticals.com. The tablets should be stored at 20° to 25°C (88 0 77°F) in a light-resistant container. The label shows that this medication is distributed by Nentacrd and manufactured by MAJOR PHARMACEUTICALS, located in Michigan. However, part of the text is illegible.*
Image 03
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.